Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2012
03/20/2012CA2392453C Modulation of signal transduction
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/15/2012WO2012034039A2 Anti-il-1 beta antibodies and methods of use
03/15/2012WO2012033390A2 Novel thiophene derivative as sglt2 inhibitor and pharmaceutical composition comprising same
03/15/2012WO2012033378A2 Composition comprising cudrania tricuspidata and coix lachryma-jobi having an obesity-suppressing activity and blood-sugar lowering effect, and a use therefor
03/15/2012WO2012033353A2 Sesterterpene compounds and use thereof
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012WO2012032014A1 Ethyne derivatives, pharmaceutical compositions and uses thereof
03/15/2012WO2012031518A1 Localized pegylated modifications of exendin-4 analogs and use thereof
03/15/2012WO2012031382A1 Special nutrient supplements for pregnant women
03/15/2012WO2012011129A3 Novel polymorph of bis[(e)-7-[4-(4-fluorophenyl)-6-iso-propyl-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt
03/15/2012WO2011150286A3 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012WO2011130611A3 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
03/15/2012WO2011020319A8 Fusion protein regulating plasma glucose and lipid, its preparation method and use
03/15/2012US20120066775 Stresscopins and their Uses
03/15/2012US20120065271 Method of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065267 Compositions including 3,5-l-t2 and methods of use thereof
03/15/2012US20120065264 SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID
03/15/2012US20120065260 Novel compounds
03/15/2012US20120065252 Engineered nucleic acids and methods of use thereof
03/15/2012US20120065236 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065209 TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF
03/15/2012US20120065207 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065205 Pyrazine carboxamide orexin receptor antagonists
03/15/2012US20120065203 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065196 Amide compounds
03/15/2012US20120065193 Cyclopropyl Amide Derivatives '978
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065168 Pharmaceutical Hypocholesterolemic Compositions
03/15/2012US20120065154 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof
03/15/2012US20120065151 Substances Mixture, Use and Infusion Solution
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof
03/15/2012US20120064170 Gallium-Doped Phosphocalcic Compounds
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064149 High-clarity aqueous concentrates of 4-hexylresorcinol
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064095 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064058 Compositions for protein-based dietary products
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064039 Use of Guanylyl Cyclase C Agonists to Suppress Appetite
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064025 Quinazolinone Modulators Of Nuclear Receptors
03/15/2012US20120064006 Systems and methods for using physiological information
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2811145A1 Sesterterpene compound and use thereof
03/15/2012CA2811025A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012CA2810844A1 Treatment of diseases
03/15/2012CA2810793A1 Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
03/15/2012CA2806698A1 Dietary supplement and methods of use thereof
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2427490A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/14/2012EP2427465A1 Substituted spirocyclic amines useful as antidiabetic compounds
03/14/2012EP2427460A1 Novel isoquinoline derivatives
03/14/2012EP2427450A1 Gpr 119 modulators
03/14/2012EP2427448A1 Gpr 119 modulators
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427415A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
03/14/2012EP2427183A2 Therapeutic compounds
03/14/2012EP2240474B1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
03/14/2012EP2141155B1 Prophylactic and/or therapeutic agent for hyperlipidemia
03/14/2012EP2086975B1 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
03/14/2012EP1519743B1 Use of an interleukin 1 receptor antagonist alone or in combination with pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN1939445B Preparation and use for loquat-leaf extract
03/14/2012CN1939444B Preparation and use for loquat-shell aqueous extract
03/14/2012CN1905863B Methods and compositions for the treatment of metabolic disorders
03/14/2012CN102378757A Pyrimidine compound
03/14/2012CN102373218A Nucleic acid sequence coding Momordica charantia polypeptide P
03/14/2012CN102373210A MicroRNA (Ribonucleic Acid) relevant to diabetes mellitus endothelial progenitor cell paralysis and application thereof
03/14/2012CN102373140A Red wine and its preparation method
03/14/2012CN102373135A Mulberry leaf scented rice wine
03/14/2012CN102372794A Method for preparing chondroitin sulfate
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372741A Zoledronic acid crystal and lyophilized powder injection thereof
03/14/2012CN102372730A Bridged ring substituted phosphodiesterase inhibitor
03/14/2012CN102372722A C-aryl glucoside derivative, preparation method thereof and application of C-aryl glucoside derivative in medicine
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102372701A Azabicyclo hexane derivative, preparation method, and application of azabicyclo hexane derivative in medicine
03/14/2012CN102372653A Diphenyl methanol derivative, preparation method thereof and application of diphenyl methanol derivative in medicine
03/14/2012CN102370866A Medicinal composition for preventing and treating diabetic nerve pathology
03/14/2012CN102370763A Application of Chinese medicinal herb immature bitter orange extract to preparation of weight-reducing and lipid-lowering medicament or preparation of medicament having lipase activity suppressing effect
03/14/2012CN102370750A New application of prune wine in medicine and health care
03/14/2012CN102370748A Orally-taken drug for breast augmentation by traditional Chinese medicine
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 1298